TRANSMEDICS GROUP, INC

TRANSMEDICS GROUP, INC

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable... perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.

Transmedics Group, Inc_logo

Industry:
Medical Device Company

Address:
200 Minuteman Road, Andover, MA, United States Zipcode 01810

Country:
United States

Phone:
978 552 0900

Market Cap:
782.51M
Total Revenue:
25.64M
Total Assets:
152.03M
Total Cash:
24.58M

Founder: Waleed Hassanein


Key Executives
Name Title Pay Year Born
Dr. Waleed H. Hassanein Founder, MD, CEO, Pres & Director 808,815$ 1968(52 years old)
Mr. Stephen Gordon CFO. Treasurer & Sec. 491,923$ 1968(52 years old)
Dr. Tamer I. Khayal Chief Commercial Officer 522,519$ 1969(51 years old)
Mr. John F. Carey VP of Operations N/A 1965(55 years old)
Mr. Ike Okonkwo VP of Fin. & Accounting N/A 1971(49 years old)
Mr. Mark Anderson Sr. Director of Technology Devel. N/A N/A
Ms. Susan Goodman VP of HR N/A N/A



Financial & Stock
Exchange NasdaqGM. Currency in USD. Market state REGULAR
According to Transmedics Group, Inc's financial reports the company's revenue in 2020 were 25.64M an increase( +8.7%) over the years 2019 revenue that were of 23.6M. In 2020 the company's total earnings were -28.75M while total earnings in 2019 were -33.55M(-15.15%).
Company's stock symbol is TMDX. Lastest price : 28.59. Total volume :372.08k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.transmedics.com

  • Host name: 10.53.185.35.bc.googleusercontent.com
  • IP address: 35.185.53.10
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...
Loading ...


More informations about "Transmedics Group, Inc" on Search Engine

Home - Transmedics

Transmedics.com TransMedics OCS: The first and only multi-organ platform to leverage proprietary core technologies across multiple organs.

Home - Transmedics

Transmedics.com TransMedics is a fast-growing medical device company committed to creating technology …

Home - Transmedics

Transmedics.com TransMedics was founded to address the growing need for healthier organs for …

Home - Transmedics

Transmedics.com CORPORATE HEADQUARTERS TransMedics, Inc. 200 Minuteman Road …

Home - Transmedics

Transmedics.com Often referred to as a “Lung-in-a-Box”, the OCS Lung is a revolutionary system that …

Home - Transmedics

Transmedics.com Often referred to as a “Heart-in-a-Box”, the OCS Heart™ is a revolutionary system that …

Home - Transmedics

Transmedics.com TransMedics has a substantial body of clinical evidence. Leading transplant programs …

Home - Transmedics

Transmedics.com Learn more about OCS Liver, including clinical study for utilized and untilized donor livers. …

Home - Transmedics

Transmedics.com Prior to joining TransMedics, Mr. Anderson served as R&D Manager of Software and …

Home - Transmedics

Transmedics.com The Only Fully-Integrated, Compact, Portable Organ System.Shown to Improve Clinical …

TransMedics Group, Inc. (TMDX) Stock Price, News, Quote

Finance.yahoo.com TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure,...

TransMedics Group, Inc. (TMDX) Company Profile & Facts

Finance.yahoo.com TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and...

Short term estimates and forecasts for TransMedics Group

Marketingsentinel.com 17 hours ago · TransMedics Group, Inc. (NASDAQ:TMDX) has a beta value of 0 and has seen 1,029,100 shares traded in the last trading session. The company, currently valued at $783.06 Million, closed the last trade at $28.61 per share which meant it lost -$3.15 on the day or …

TMDX Stock Price | TransMedics Group Inc. Stock Quote (U.S)

Marketwatch.com Apr 09, 2021 · TransMedics Group Inc. TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of …

TransMedics Group, Inc. (TMDX) Q3 2020 Earnings Call

Fool.com Nov 04, 2020 · TransMedics Group, Inc. (NASDAQ:TMDX) Q3 2020 Earnings Call Nov 4, 2020, 4:30 p.m. ET Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Ladies and ...

TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by

Themarketsdaily.com Mar 25, 2021 · TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in …

TransMedics Group Inc (TMDX : NASDAQ) Stock Price & News

Google.com Get the latest TransMedics Group Inc (TMDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

TransMedics Group, Inc. (NASDAQ:TMDX) Surprises Bull With

Marketingsentinel.com Apr 05, 2021 · TransMedics Group, Inc. share prices are not performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen +190.78 percent over the past six months and at a -24.14% annual growth rate that is well below the industry average of 22.2%.

TransMedics Group, Inc. (NASDAQ:TMDX) Short Interest

Marketbeat.com Mar 16, 2021 · TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in …

TransMedics Group Inc. (TMDX) Reveals an Earnings Mystery

Newsheater.com Mar 16, 2021 · TransMedics Group Inc. (NASDAQ:TMDX) went up by 18.55% from its latest closing price compared to the recent 1-year high of $44.12. The company’s stock price has collected 35.71% of gains in the last five trading sessions. Press Release reported on 03/02/21 that TransMedics Reports Fourth Quarter and Full Year 2020 Financial Results

Transmedics Group, Inc. - TMDX - Stock Price Today - Zacks

Zacks.com Apr 09, 2021 · View TransMedics Group, Inc. TMDX investment & stock information. Get the latest TransMedics Group, Inc. TMDX detailed stock quotes, stock …

Time To Get Constructive: Halliburton Company (HAL) and

Bovnews.com Mar 22, 2021 · TransMedics Group Inc. (TMDX) shares on Friday’s trading session, jumped 5.93 percent to see the stock exchange hands at $44.29 per unit. Lets a quick look at company’s past reported and future predictions of growth using the EPS Growth. EPS growth is a percentage change in standardized earnings per share over the trailing-twelve-month ...

Transmedics Group Inc Stock Quote: TMDX Stock News, Quotes

Research.investors.com Transmedics Group Inc (TMDX) - DEVELOPS PORTABLE WARM BLOOD PERFUSION SYSTEM THAT ALLOWS FOR LIVING ORGAN TRANSPLANT.

TransMedics Group, Inc. (TMDX) CEO Waleed Hassanein on Q2

Seekingalpha.com Aug 10, 2020 · TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2020 Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants. Brian Johnston - Vice President, Investor Relations-Gilmartin Group. Waleed ...

TransMedics Group, Inc. (NASDAQ:TMDX)’s stock hinders -13

Stocksregister.com Apr 06, 2021 · To see how TransMedics Group, Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: TMDX stock’s performance was -13.85% in the latest trading, and +183.88% in the past year, while Thermo Fisher Scientific Inc (TMO) has traded +1.99% on the day and positioned +61.85% higher than it was a year ago.

TMDX Company Profile & Executives - TransMedics Group Inc

Wsj.com Stephanie Lovell Director, TransMedics Group, Inc. Stephanie Lovell founded The New Commonwealth Racial Equity & Social Justice Fund, Inc. Ms. Lovell is Chief Legal Officer & Executive VP-Medicare ...

TransMedics Group, Inc. (TMDX) Valuation Measures

Finance.yahoo.com Find out all the key statistics for TransMedics Group, Inc. (TMDX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

TMDX | TransMedics Group Inc. Stock Price & News - WSJ

Wsj.com View the latest TransMedics Group Inc. (TMDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

TransMedics Group Inc. [TMDX] Stock trading around $42.94

Dbtnews.com Mar 16, 2021 · TransMedics Group Inc. [NASDAQ: TMDX] stock went on an upward path that rose over 18.55% on Monday, amounting to a one-week price increase of more than 35.71%. The company report on March 3, 2021 that TransMedics Reports Fourth Quarter and Full Year 2020 Financial Results. Get the hottest stocks to trade every day before the market opens 100% free.

TransMedics Group, Inc. (NASDAQ:TMDX): Trading Information

Marketingsentinel.com Apr 08, 2021 · TransMedics Group, Inc. (NASDAQ:TMDX)’s Biggest Investors. TransMedics Group, Inc. insiders own 6.77% of total outstanding shares while institutional holders control 71.54%, with the float percentage being 76.74%. FMR, LLC is the largest shareholder of the company, while 110 institutions own stock in it.

TransMedics Group, Inc. to Host Earnings Call

Finance.yahoo.com NEW YORK, NY / ACCESSWIRE / March 2, 2021 / TransMedics Group, Inc. (NASDAQ:TMDX) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 2, 2021 ...

TransMedics Group, Inc. 10-K Mar. 17, 2020 4:15 PM

Seekingalpha.com About: TransMedics Group, Inc. (TMDX) View as PDF UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF ...

Insider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) VP

Themarketsdaily.com Mar 14, 2021 · TransMedics Group, Inc. (NASDAQ:TMDX) VP John F. Carey sold 3,200 shares of the company’s stock in a transaction that occurred on Thursday, March 11th. The stock was sold at an average price of ...

Transmedics Group Inc, TMDX:NMQ profile - FT.com

Markets.ft.com Transmedics group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed organ care system (OCS) ...

Short Interest in TransMedics Group, Inc. (NASDAQ:TMDX)

Marketbeat.com Mar 30, 2021 · TransMedics Group, Inc. (NASDAQ:TMDX) was the recipient of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 744,400 shares, a decrease of 35.3% from the February 28th total of 1,150,000 shares. Based on an average daily trading volume, of 668,500 shares, the days-to-cover ratio is presently 1.1 days.

TMDX:NASDAQ GM Stock Quote - TransMedics Group Inc

Bloomberg.com About TransMedics Group Inc TransMedics Group, Inc. operates as a biotechnology company. The Company offers transplant therapy for end-stage organ failure patients across multiple disease states.

Transmedic

Transmedicgroup.com Transmedic was honoured to be part of this year’s Singapore Orthopaedic Association 41st Annual Scientific Meeting as a Gold Sponsor. The Singapore Orthopaedic Association (SOA) was formed to actively advance orthopaedic surgery in the Republic, while promoting the relationship between SOA and the various Orthopaedic realms from around the world.

Laura Damme, TransMedics Group Inc: Profile and Biography

Bloomberg.com TransMedics Group, Inc. operates as a biotechnology company. The Company offers transplant therapy for end-stage organ failure patients across multiple disease states.

How Jonah Lupton Expects TransMedics Group Stock To React

Benzinga.com Jonah Lupton of Lupton Capital was focused on TransMedics Group Inc (NASDAQ: TMDX) Tuesday. The Nasdaq halted trading in TransMedics stock while …

TransMedics Group Inc. (TMDX) Stock Message Board

Investorshub.advfn.com Apr 07, 2021 · TransMedics Late Tuesday Announced FDA Advisory Committee Panel: crudeoil24: 04/07/21 07:28:29 AM #1 Transmedics group, Inc. is a commercial-stage medical technology: crudeoil24: 04/07/21 07:26:42 AM: Post: Subject

TransMedics Group Inc. Stock Price (TMDX) | Barron's

Barrons.com May 15, 2020 · View today's stock price, news and analysis for TransMedics Group Inc. (TMDX). Barron's also provides information on historical stock ratings, …

TMDX TransMedics Group, Inc. Stock Quote

Finviz.com TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and ...

TransMedics Group Inc (TMDX) Stock Price, News & Info

Fool.com TransMedics Group, Inc. (TMDX) Q4 2019 Earnings Call Transcript Motley Fool Transcribers | Mar 2, 2020 TMDX earnings call for the period ending December 28, 2019.

TransMedics Group, Inc. (NASDAQ:TMDX) – Analyst View Looks

Marketingsentinel.com Mar 08, 2021 · TransMedics Group, Inc. (NASDAQ:TMDX)’s Major holders. If we look at who the major shareholders are, we find that insiders hold 11.86% of TransMedics Group, Inc. shares while 78.32% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 88.86%.

Time to Buy Beat-Down TransMedics Group Inc. (TMDX) Stock

Investchronicle.com Apr 06, 2021 · TransMedics Group Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $49.50 on 03/22/21, with the lowest value was $17.19 for the same time period, recorded on 01/07/21.

TransMedics Group Inc. (TMDX): Skating on Thin Ice? We

Newsheater.com 17 hours ago · TransMedics Group Inc. (NASDAQ:TMDX) went down by -9.92% from its latest closing price compared to the recent 1-year high of $49.50. The company’s stock price has collected -28.60% of loss in the last five trading sessions. Press Release reported on 04/06/21 that TransMedics …

TransMedics Group, Inc. to Host Earnings Call

Finance.yahoo.com Nov 05, 2020 · NEW YORK, NY / ACCESSWIRE / November 4, 2020 / TransMedics Group, Inc. (TMDX) (NASDAQ:TMDX) will be discussing their earnings results in their call to be held on November 4, 2020 at 4:30 PM ...

TransMedics Group Inc (TMDX) has gained 7.69% Wednesday In

Investorsobserver.com Mar 17, 2021 · TransMedics Group Inc (TransMedics Group Inc is lower by Wednesday morning, with the stock falling -7.69% in pre-market trading to 39.5.TMDX's short-term technical score of 54 indicates that the stock has traded more bullishly over the last month than 54% of stocks on the market.

Top Moving Stock Now – TransMedics Group, Inc. (NASDAQ)

Stocksregister.com Mar 27, 2021 · In comparing TransMedics Group, Inc. (TMDX)’s stock with other industry players reveals that stock’s current price change of -4.12% and that of +208.46% over the past 12 months is in competing position with that of Thermo Fisher Scientific Inc (TMO) which saw its stock price raised by 4.02% in the last trading and went through an increase of 62.48% in past 12-month trading.

TransMedics Group, Inc. (Form: S-1/A, Received: 04/22/2019)

Content.edgar-online.com TransMedics Group, Inc. COMMON STOCK TransMedics Group, Inc. is offering 4,700,000 shares of common stock. This is our initial public offering, and no public market currently exists for our common stock. We anticipate that the initial public offering price will be between $15.00 and $17.00 per share.